Ray Dalio acquired 54.4 Thousand United Therapeutics shares worth $11.3 Million. That's 0.05% of their equity portfolio (295th largest holding). The first United Therapeutics trade was made in Q4 2015. Since then Ray Dalio bought shares ten more times and sold shares on five occasions. The stake costed the investor $11.1 Million, netting the investor a gain of 2.3% so far.